Fosamprenavir
Back to searchMolecule Structure
Scientific Name
Fosamprenavir
Description of the Drug
Fosamprenavir is an antiretroviral agent used for the treatment and postexposure prophylaxis of human immunodeficiency virus (HIV-1) infection.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01319
http://www.drugbank.ca/drugs/DB01319
Brand Name(s)
Not Available
Company Owner(s)
Sun Pharmaceutical Industries Ltd, Viiv Healthcare Co, Mylan Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Human immunodeficiency virus type 1 protease | SINGLE PROTEIN | INHIBITOR | CHEMBL243 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL34080 | ||
| PharmGKB | PA10084 | ||
| Human Metabolome Database | HMDB0015416 | ||
| DrugBank | DB01319 | ||
| PubChem: Thomson Pharma | 14911487 | 14764609 | |
| PubChem | 131536 | ||
| Nikkaji | J1.972.383F | ||
| EPA CompTox Dashboard | DTXSID2048296 | ||
| DrugCentral | 1240 | ||
| Brenda | 167956 | ||
| ChemicalBook | CB41178812 | ||
| rxnorm | FOSAMPRENAVIR CALCIUM | FOSAMPRENAVIR | LEXIVA |
| ChEBI | 82941 | ||
| ZINC | ZINC000003941829 |
